Breast Cancer
People diagnosed with metastatic breast cancer have a notably increased risk of developing heart disease.
Dr. Sadie Debrozsi discusses the importance of "pan-cancer" testing, especially as it pertains to breast cancer.
The CDK4/6 inhibitor showed meaningful improvement in HR+, HER+ disease.
The positive predictive value for cancer was 15% higher for those enrolled.
The most frequent changes detected were additional copies of chromosome 1q and losses of chromosomes 10q, 16q, and 22.
Twelve chemicals were associated with increased breast cancer risk.
Heterozygosity in BRCA1 genes is not enough to prevent tumor proliferation, according to researchers out of Harvard.
Thyroid and parathyroid dysfunction is common among women with breast cancer following radiotherapy.
A study aimed to assess TILs as predictors of response to neoadjuvant chemotherapy in locally advanced breast cancer.
Researchers designed a interpretable deep learning model for detecting BRCA pathogenic variants of breast cancer.
Advertisement
Expert Interviews on Oncology
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
Advertisement
Section Editor
Dr. Sadie Dobrozsi, EvolentHematologist/oncologist and Medical Director, Evolent
Advertisement
Latest News
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.